The Access to Advanced Health Institute Reports Encouraging Results of First-In-Human Trial of Its Temperature-Stable Tuberculosis Vaccine Candidate
SEATTLE–(BUSINESS WIRE)–The Access to Advanced Health Institute (AAHI) published results of a Phase 1 clinical…